Pharma & Banking Regulatory Enforcement Wave

A convergence of cross-sector regulatory enforcement actions — including Bank of Italy control flags triggering a 12% collapse in Banca Ifis, US asset seizures affecting Tether's EQIBank exposure, and Viatris challenging Novo Nordisk's Wegovy patent — is forcing a sharp repricing of compliance and legal risk across banking equities, stablecoins, and pharmaceutical names. Investors are reassessing regulatory overhang across financial institutions, stablecoin issuers, and blockbuster drug incumbents as enforcement actions escalate from warnings into market-moving consequences.